IPTLD®

Insulin Potentiation Therapy was initially developed by my grandfather, Donato Pérez García, Sr. M.D.
IPT targets the treatment of a cell by changing the bio-physio-chemical constants and parameters of the blood. This pathway initially attacks the cancerous cell itself through its intra-cellular environment and extra-cellular environment by permeabilizing the cell membrane via insulin.

IPT is a targeted therapy for cancer and chronic disease; the power of chemotherapy is directed only to cancer cells and not a patient’s entire body. In addition, the chemo is delivered at a fraction of the normal dose. This approach eliminates or significantly reduces the dreaded side-effects of conventional chemo. IPTLD annihilates cancer cells by employing the very same mechanisms that cancer cells utilize to kill people.

IPTLD® a Registered Trademark by Donato Perez Garcia,MD
Copyright ©1930-2017 Donato Perez Garcia.



Wednesday, August 21, 2013

FAQ'S & FREQUENT QUESTIONS ABOUT I.P.T. PART 2

LEARN THE FACTS AND MOST FREQUENT QUESTIONS ABOUT I.P.T.

VI.   What’s the difference between High/Low Dose Chemo Vs. IPT?
VII.  What’s the history behind IPT?
VIII. Who can receive IPT?
IX.    Why is IPT better than getting traditional chemo?
X.     Where can I find more information on IPT and Dr. Donato Pérez García?

VI.

Traditional High/Low Dose Chemo

- Only uses Chemotherapy.

-Traditional Chemo, either in high or low dose, will attack healthy cells, as well as cancerous cells.

-The patient’s level of toxicity will increase and the side effects will decrease the patient’s quality of life.

-Chemo remains in the Extracellular fluid, waiting until cells open up and ingest the anti cancer drugs.

-Because traditional chemo attacks good cells as well as cancerous, the body is weak; the immune system is slower, leaving you unprotected from cancer agents spreading.

-The intervals between Traditional chemotherapy are longer and takes more time for patients to recuperate, extending the length of treatment, and inevitably more expensive in the far future.

- You’ll only get very strong medication, nothing to complement the body’s true healing system.

Insulin Potentiation Targeted Therapy

- Uses human insulin to prepare your body to receive the anti drug medication.

-Because cancer cells contain 6 times more insulin receptors than healthy cells, IPT can target chemotherapy directly and only to cancerous cells, leaving healthy cells in tacked.

- IPT can deliver chemo directly into cancer cells, knowing the precise moment when the body is at its best moment to receive medication.

-The level of toxicity is reduced; side effects from chemotherapy are scarce even absent.

-Because there is less toxicity using IPT, treatments can be more often, up to 2 times per week.

-Another property of Insulin is that it promotes permeability in the cancerous cell membrane, so it opens up easily, making the ingestion of chemo swift and consumed entirely.
-With Insulin Potentiation Targeted Therapy, you will also get a detoxification program; substantial nutrients and immune boosters that will help restore and maintain the body’s natural defenses against other cancer agents.

-This procedure is very safe when administered by a trained IPT Physician, as Dr. Donato Perez Garcia. No reports of death or life threat have ever been reported.

-This protocol will leave you with more energy and vitality to heal and do the things you love.

VII.

Insulin Potentiation Therapy (IPT) was invented in 1930 by a surgeon lieutenant of the Mexican military, Dr. Donato Pérez García, Sr. (1896-1971), as a remedy for chronic degenerative diseases. Insulin was first isolated from pancreatic tissue in Canada and used as a treatment for diabetes in early 1920's, years later in Europe and in the USA, insulin was used to produce coma for short periods in patients with schizophrenia in an attempt to cure them. Among other uses, was to treat some forms of malnutrition. So when Donato first learned about insulin's discovery he formulated an experiment on himself, in search of a cure for his lifelong severe gastrointestinal problems.

In 1926, a non-diabetic first injected himself with insulin, proving it was safe and efficient.  After a series of treatments, his symptoms disappeared; he recovered appetite and full health again. The idea was that insulin helped his body tissues assimilate nutrients more efficiently and pondered that could just as well work with medication. Insulin could increase drug concentration potency in the central nervous system, given before various medications, changing the physical and chemical reactions that occurred in the blood, restoring balance and maintaining a state of good health. And it did. In 1930, Dr. Donato successfully treated a patient with neurosyphilis using the name of Cellular Therapy, later known as IPT.

Five years later he applied for U.S. patent of the treatment, where it was granted in 1938. He traveled along the United States demonstrating his medical protocol, at Harvard University, Saint Elizabeth’s Hospital in Washington, D.C., Naval Hospital in San Diego, California and Austin State Hospital in Texas where he treated patients. In Mexico City he opened up a clinic exclusively for IPT. In 1946 the first breast cancer patient was successfully treated.  Many other chronic degenerative illnesses also responded to this innovative breakthrough.
Later on, his son, Dr. Donato Pérez García Bellón (1930-2000) joined his father in the medical field, learning and perfecting the treatment. His clinical research was to measure chemical modifications produced in the blood after the administration of insulin, along with other chemical experiments and international publications that gave IPT full scientific ground. Together, father and son traveled to Canada, United States and Europe giving a series of conferences to medical societies.

After his father’s passing, Donato Pérez Bellón continued in his footsteps.

In 1974 he use the name "Donatian Therapy" to his adaptation of the treatment and these were the modifications he introduced:

1. A cleansing enema prior to the treatment using flax seed and leafs of senna boiled in water.
2. A nasal administration of oxygen during the procedure.
3. He developed some formulas of his own to treat some cancers and one was a vaginal insert to treat cervical cancer in which he mixed several substances. This vaginal insert was placed after the patient had emptied her bowels.
4. Even created a device that could diagnose cancer, called “El Oncodiagnosticador”.

He allied with Dr. Steven G. Ayre, and the M.D. Anderson, together promoted Insulin Potentiation Therapy in the United States, as well as training physicians worldwide.  Cases of Polio, Multiple sclerosis, gastric and duodenal ulcers, chronic infections, HIV/AIDS and other viral diseases where effectively treated with this protocol. But out of all, it was Cancer that he focused more, learning about improvements and adaptations, as new drugs were available.
Finally, the third generation of IPT came along with Dr. Donato Pérez García, who learned the protocol from his father. By December of 1982, he introduced the intravenous use of insulin to patients receiving the treatment. Later that month Dr. Donato implemented the first modification of the administration procedure and patients began with the new routine. By 1986 the name “Insulin Potentiation Therapy” was given by Dr. Ayre. Today the name of this therapy is “Insulin Potentiation Therapy + Targeted Low Dose” or IPTLD ® (a trademark) and it is comprised of a combination of the best-developed protocols. Thousands of patients treated by three Donato generations of medical doctors till this day.

VIII.

Any one with a chronic illness, such as cancer, whatever stage. Insulin Potentiation Targeted Therapy is a safe procedure when administered by an experienced certified IPT trained doctor. In the vast majority of patients there are no side effects or complications. Treatments are usually every 7 days but for some cases 2 treatments per week can be administered. No cases of death while undergoing IPT have been reported.

IX.

It has been said that, when treating cancer, the cure is by far worse than the illness itself. If you’re a cancer patient and been thru several full dosage chemotherapy, you know what we’re talking about, if you’d had a friend or relative go thru this, you know what we’re talking about.
Very often patients relate chemotherapy with fear, if you’ve been there; you know how bad the side effects can be. Unfortunately, what people don’t know is that it’s not the chemo what makes it so dreadful, but rather the dosage.

Side effects of high dosage chemo include:
*Immune system decrease
*Gastrointestinal distress (nausea, vomit, diarrhea, constipation, malnutrition, dehydration, weight loss...).
*Fatigue
*Anemia
*Tendency to bleed easily
*Partial/Full hair loss.
*Cytotoxicity
*Encephalopathy
*Nephrotoxicity...

The list goes on and on and on...
Since 1942, there have been many chemotherapy drugs, most of them are derived from poisonous plant extracts, and they’re powerful agents that can kill human cells by the bunch. Unfortunately chemo itself makes no distinction between healthy and sick cells, it just kills cells. Because every human handles disease differently, same goes with medication. For some, high dose chemo is the answer, and has saved lives at a great cost of pain and discomfort, but many others cannot handle such strong medication, their bodies cannot take it and sadly die.

Some decades ago there was probably no other option, but today there is a better, smarter way to do chemo. Using Insulin Potentiation Targeted Therapy.
IPTLD uses insulin to target only cancer cells, help them open up their membrane to let all the medication inside the damaged cell using less than half the dosage of traditional chemo sessions, thus reducing even eliminating all the horrid side effects. That means more energy, less chemo less toxicity, gentler on your body; potent and precise on cancer cell annihilation. IPT will also provide detoxification, immune boosters and essential nutrients to strengthen your natural defenses against any other carcinogenic agents, helping your own body defend itself not just the chemo.

X.

For more information on IPT and Dr. Donato Pérez García

You can visit our web sites:

Read our Blogs:
IPTLD for Cancer and Chronic Degenerative Diseases Treatment by Donato Perez Garcia, MD

Facebook:
IPTLD for Cancer & Chronic Degenerative Diseases
https://www.facebook.com/IPTLD

Twitter:
Dr Donato Perez Garcia

Pinterest

Google+

LinkedIN
http://mx.linkedin.com/in/drdonatoperezgarcia


YouTube:
Donato Perez Garcia, M.D.

Read the Biographic Novel of Donato Pérez García:
“Did Mr. Eo Confirm for treatment?” by Donato Perez Garcia, M.D.

Contact Us:

We are located:
Medical Building Tower at Hospital Angeles Tijuana
Ave. Paseo de los Héroes #10999, Office 607
Zona Urbána Río, Tijuana, Baja California, 22010. México.

Office Phone number:
(you are welcome to call us during our business hours, when making the phone call consider that our local time is Pacific Standard Time or GMT-8).

From US: 011-52-(664)-635-1864
From US: 011-52-(664)-635-1834
U.S. Number: (619)-798-8017
U.S. Fax: (619)-330-1978

Office Business hours:

Monday thru Friday (Pacific Standard Time GMT-8)
9:00 am – 2:00 pm
2:00 pm - 4:00 pm office is closed for lunch
4:00 pm – 6:30 pm

Saturdays (Pacific Standard Time GMT-8)
9:00 am – 1:00 pm

Email
info@iptldmd.com

Friday, August 16, 2013

FAQ’s & FREQUENT QUESTIONS ABOUT I.P.T. PART 1

LEARN THE FACTS AND MOST FREQUENT QUESTIONS ABOUT I.P.T.

I.     What is IPT?
II.    How does it work?
III.  Scientific explanation
IV.  Who administers these treatments?
V.    What types of cancer does IPT treat?


I.

IPT stands for Insulin Potentiation Therapy, discovered by Dr. Donato Perez Garcia in Mexico City, 1930. It is a patented medical protocol used to treat cancer with less dosage of chemotherapy, using insulin as a natural potentiator that targets only cancer cells, reducing chemotherapy’s toxic side effects, adding natural and biologic medicine to help restore the body’s natural defenses. It has been developed and researched for over 80 years; today it is administered by the grandson of the founder, also named Donato Perez Garcia, M.D.
IPT, subsequently developed in Insulin Potentiation Targeted Low Dose (IPTLD), is a treatment that has cured cancer patients, of all types and stages, around the world. There are more than 451 doctors practicing this protocol in more than 31 countries worldwide.

II.

Let’s define cancer as a loss of harmony and complete disorder of normal physical and chemical functioning in the body, activated by a cancer genic agent.
It all starts with insulin; a hormone produced in the pancreas that regulates metabolism of carbohydrates, fat and excess glucose from the blood. But it has many more functions on a cellular level. With a single shot, Insulin Potentiation Therapy uses insulin to modify cancer cells molecular biology, inducing a controlled state of hypoglycemia. And because a cancer cells contains 10 times more insulin receptors than healthy cells, insulin can help target the medication only to cancer cells. Once it has reached them, insulin promotes the permeabilization of the cell’s membrane. Only a trained IPT medical physician will know the exact timing when this happens, also known as “The Therapeutic Moment”, that’s when all chemotherapy drugs are administered thru I.V. in far less amounts into the patient. Insulin Potentiation Targeted Therapy changes the   bio-physic-chemical constants and parameters of the blood, attacking first the cancerous cell through its intra-extra cellular environment, permeabilizing the cell’s membrane. This permeabilization assures that anticancer medication will effectively enter the damaged cells and eventually kill them, reducing the affected cancer tissue.

The administration of chemo is so effective that IPT only uses less than half the dosage of what you’d receive in a traditional chemotherapy session. This will dramatically reduce your level of toxicity (cause by chemotherapy’s strong medication), with hardly any side effects, giving you more energy and vitality to fight the disease and live a healthy life.

As part of an IPT treatment, you will also receive a detoxification protocol of biologic medicine, essential nutrients and immune boosters that will fortified your white cells, helping your own body defend itself against any cancer agent. Healthy cells remain intact, thus promoting a better quality of life, while fighting the disease. It is a potent, effective treatment for cancer, in a gentler, kinder way that wont damage or exert your body. It is the next generation for administering chemotherapy.

III.

Insulin Potentiation Therapy + Targeted Low Dose (IPTLD ®) manipulates the mechanisms of malignancy to therapeutic advantage by employing insulin as a biologic response modifier of cancer cells endogenous molecular biology. The autonomous proliferation of malignancy is supported by autocrine secretion of insulin for glucose/energy uptake by cancer cells, and a similar autocrine and/or paracrine elaboration of cellular factors to stimulate cancer growth. Amongst these, the insulin-like growth factors have been identified as the most potent mitogens for cancer cells.

Of primary importance for IPTLD ®, cancer cell membranes also have six times more insulin receptors and ten times more IGF receptors, per cell, than the membranes of host normal tissues. Further, insulin can cross-react with and activate cancer cell IGF receptors. Thus, per cell, cancer has sixteen times more insulin-sensitive receptors than normal tissues. As ligand effect is a function of receptor concentration, these facts serve to differentiate cancer from normal cells - a vital consideration for the safety of cancer chemotherapy. In light of these revelations, exogenous insulin acts to enhance anticancer drug cytotoxicity, and safety, via:

1) A membrane permeability effect to increase the intracellular dose intensity of the drugs;
2) An effect of metabolic modification to increase the S-phase fraction in cancer cells, enhancing their susceptibility to cell-cycle phase-specific agents, and;
3) An effect of biochemical differentiation based on insulin receptor concentration that focuses the first two insulin effects predominantly on cancer cells, sparing host normal tissues.

Significantly fewer drugs can thus be targeted more specifically and more effectively to cancer cell populations that are more susceptible to the chemotherapy drug effects, all this occurring with a virtual elimination of the dose-related side effects of these powerful drugs.

Because of this favorable decrease of side effects, cycles of low-dose chemotherapy with IPTLD ® may be done more frequently. There is good patient acceptance of the hypoglycemic side effect of insulin in this protocol, and the "rescue phenomenon" occasioned by the timely administration of hypertonic glucose actually serves to provide patients with an experiential metaphor for the rapid recovery of their well being. It is acknowledged that cancer treatment can often be debilitating for patients. In those undergoing treatment with IPTLD ®, an overall gentler experience promotes their concurrent use of other important elements in a program of Comprehensive Cancer Care.

IV.

The most experienced IPT Medical Doctor is Donato Perez Garcia. He is the 3rd generation of IPT physicians, all of the same name. In 1982 he began working with his father, Donato Pérez García Bellón, where he learned the therapy discovered by his grandfather. Together they attended several conferences within the Mexican republic, then the United States and Europe.
In February of 2001, he conducted the first IPT training seminar in the city of Las Vegas, where 21 doctors from the United States and Canada attended. During the following years he dedicated himself in introducing the treatment in Mexico, South America, Europe, Asia and North Africa, training physicians that offer IPT as an option for treating cancer and other degenerative diseases. Since then, he’s continued with annual seminars, attended by international doctors and presentations on IPTLD® to the United States government organization NIH/NCI/OCCAM.

In 2002 he held the first IPT Non-Profit Congress, where physicians could exchange scientific knowledge. Few years ago, he was invited to open an office in the Medical Consultation Tower in Hospital Angeles de Tijuana. During this period he started making changes to the treatment administration protocol, now formally called Insulin Potentiation Targeted Low Dose (IPTLD). He currently practices medicine in Hospital Angeles in Tijuana, Baja California, Mexico. On January of 2013 he was promoted for a three-year period as Medical Advisory in Research for the Health Committee of LXII Legislature. Chamber of Deputies. United States of Mexico. Government of Mexico.

Has over 30 years experience in IPT. Has applied over 26,000 treatments to patients worldwide.

V.

The most common are:

* Breast
* Lung
* Ovarian
* Uterine
* Prostate
* Bone
* Lymphoma
* Cervix
* Melanoma
* Renal Cell
* Fibro sarcoma
* Hodgkin's
* Leukemia